Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
European Journal of Heart Failure
|
February 24, 2015
Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials
Patrick Rossignol, Serge Masson, Simona Barlera, et al.
Journal of the American College of Cardiology
|
September 13, 2002
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
Maylene Wong, Lidia Staszewsky, Roberto Latini, et al.
Journal of Cardiac Failure
|
September 18, 2017
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial
Kay-Won Chang, Neil Beri, Nghia H Nguyen, et al.
Circulation
|
August 17, 2005
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT
Inder S Anand, Michael A Kuskowski, Thomas S Rector, et al.
Circulation
|
March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial
Anne L Taylor, Susan Ziesche, Clyde W Yancy, et al.
Journal of Cardiac Failure
|
March 31, 2009
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial
Dennis M McNamara, S William Tam, Michael L Sabolinski, et al.
Circulation
|
November 6, 2002
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)
Roberto Latini, Serge Masson, Inder Anand, et al.
Journal of the American College of Cardiology
|
October 19, 2004
Task force 2: Investigator participation in clinical research
Robert M Califf, Steven E Nissen, Anthony N DeMaria, et al.
European Journal of Heart Failure
|
December 4, 2014
Calculated plasma volume status and prognosis in chronic heart failure
Hua Zen Ling, Julia Flint, Morten Damgaard, et al.
Journal of the American College of Cardiology
|
November 3, 2018
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T
Michele Emdin, Alberto Aimo, Giuseppe Vergaro, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
European Journal of Heart Failure
|
February 24, 2015
Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials
Patrick Rossignol, Serge Masson, Simona Barlera, et al.
Journal of the American College of Cardiology
|
September 13, 2002
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
Maylene Wong, Lidia Staszewsky, Roberto Latini, et al.
Journal of Cardiac Failure
|
September 18, 2017
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial
Kay-Won Chang, Neil Beri, Nghia H Nguyen, et al.
Circulation
|
August 17, 2005
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT
Inder S Anand, Michael A Kuskowski, Thomas S Rector, et al.
Circulation
|
March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial
Anne L Taylor, Susan Ziesche, Clyde W Yancy, et al.
Journal of Cardiac Failure
|
March 31, 2009
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial
Dennis M McNamara, S William Tam, Michael L Sabolinski, et al.
Circulation
|
November 6, 2002
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)
Roberto Latini, Serge Masson, Inder Anand, et al.
Journal of the American College of Cardiology
|
October 19, 2004
Task force 2: Investigator participation in clinical research
Robert M Califf, Steven E Nissen, Anthony N DeMaria, et al.
European Journal of Heart Failure
|
December 4, 2014
Calculated plasma volume status and prognosis in chronic heart failure
Hua Zen Ling, Julia Flint, Morten Damgaard, et al.
Journal of the American College of Cardiology
|
November 3, 2018
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T
Michele Emdin, Alberto Aimo, Giuseppe Vergaro, et al.
Page
of 18